Seagen Inc. Stock price

Equities

SGEN

US81181C1045

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 01:17:40 2023-09-29 pm EDT Intraday chart for Seagen Inc. 5-day change 1st Jan Change
213.17 USD +0.44% -0.21% +65.94%
Sales 2023 * 2,407 M Sales 2024 * 3,184 M Capitalization 39 837 M
Net income 2023 * -650 M Net income 2024 * -266 M EV / Sales 2023 *
15,9x
Net cash position 2023 * 1,498 M Net cash position 2024 * 1,885 M EV / Sales 2024 *
11,9x
P/E ratio 2023 *
-62,6x
P/E ratio 2024 *
-152x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float99.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.15%
1 week+2.83%
Current month+2.99%
1 month+2.90%
3 months+9.48%
6 months+4.54%
Current year+65.15%
More quotes
1 week
212.15
Extreme 212.15
217.08
1 month
203.61
Extreme 203.605
217.08
Current year
126.47
Extreme 126.47
217.08
1 year
116.08
Extreme 116.08
217.08
3 years
105.43
Extreme 105.43
217.08
5 years
50.71
Extreme 50.71
217.08
10 years
26.02
Extreme 26.02
217.08
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 Nov. 08
Chief Tech/Sci/R&D Officer 67 2018
Director of Finance/CFO 62 2005
Members of the board TitleAgeSince
Chairman 54 2022
Director/Board Member 61 Nov. 08
Director/Board Member 62 2012
More insiders
Date Price Change Volume
23-09-29 213.27 +0.49% 580 610
23-09-28 212.24 -0.15% 1,299,094
23-09-27 212.55 -1.67% 3,383,466
23-09-26 216.16 +0.30% 2,974,834
23-09-25 215.52 +0.85% 1,876,335

Delayed Quote Nasdaq, September 28, 2023 at 04:00 pm EDT

More quotes
Seagen Inc. specializes in the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer. Net sales break down by source of income as follows: - product sales (88%); - royalties (9.6%); - licenses and collaboration agreements (2.4%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
212.24USD
Average target price
225.41USD
Spread / Average Target
+6.21%
Consensus
  1. Markets
  2. Equities
  3. Stock Seagen Inc. - Nasdaq
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer